Biolegend, 127622, Alexa Fluor® 700 anti-mouse Ly-6G Antibody
100microg
Catalog Number: 127622
Send an RFQ.
Pack Size6 g
Loading…
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Rat |
| Immunogen | Ly-6G transfected EL-4J cell line. |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions. |
| Concentration | 0.5 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | FC - Quality testedIHC - Reported in the literature, not verified in house |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Excitation Laser | Red Laser (633 nm) |
|---|
| Application Notes | While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416. Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662). |
|---|
| Application References(PubMed link indicates BioLegend citation) | Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC) Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC) Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC) Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC) Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC) Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC) Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete) Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete) Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete) Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed Ma C, et al. 2012. J. Leukoc. Biol. 92:1199. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed |
|---|
| Product Citations | Gallizioli M, et al. 2020. Cell Rep. 33:108291. PubMed Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed Ou W, et al. 2023. Nat Commun. 14:392. PubMed Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed Kaur N, et al. 2023. Heliyon. 9:e14952. PubMed Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed Zengel J, et al. 2023. Nat Methods. . PubMed Schädlich IS, et al. 2022. iScience. 25:104470. PubMed Pierson M, et al. 2021. Curr Protoc. 1:e53. PubMed Woods PS, et al. 2022. Elife. 11: . PubMed Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed Blomberg OS 2023. Cancer Cell. 41(1):106-123.e10. PubMed Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed Feng J, et al. 2022. Immunity. 55:405. PubMed Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed Dong L, et al. 2021. Cancer Cell. . PubMed Sauter M, et al. 2022. iScience. 25:103677. PubMed Hreha TN, et al. 2020. Front Immunol. 1.597916667. PubMed Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed Salas–Pérdomo A, et al. 2019. Sci Rep. 9:8309. PubMed Ma C, et al. 2018. Science. 360:eaan5931. PubMed Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed Tuit S, et al. 2019. Cell Rep. 29:1221. PubMed Lyons J, et al. 2018. Sci Signal. 11. PubMed Liang P, et al. 2022. Mol Biomed. 3:14. PubMed Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed Mainz RE, et al. 2022. Cells. 11:. PubMed Lin J, et al. 2017. Sci Rep. 7:41722. PubMed Hartwig T et al. 2018. Cell reports. 25(13):3564-3572 . PubMed Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed Pascual–García M, et al. 2019. Nat Commun. 10:2416. PubMed Lu CY, et al. 2020. J Neurosci. 40:9602. PubMed Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed Ahadome S, et al. 2016. JCI Insight. 1:e87012. PubMed Qi S et al. 2016. eLife. 5 pii: e14756. PubMed Kren N, et al. 2020. Sci Rep. 10:7390. PubMed Lewis EL, et al. 2021. Front Immunol. 12:741518. PubMed Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed Toomey CB, et al. 2018. Invest Ophthalmol Vis Sci. 59:662. PubMed Da Silva CG, et al. 2019. Theranostics. 4.878472222. PubMed Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed Gilbert NM, et al. 2021. Biol Open. 10:. PubMed Toomey C, et al. 2015. Proc Natl Acad Sci U S A. 112:3040. PubMed Jin C, et al. 2019. Cell. 176:998. PubMed Uderhardt S, et al. 2019. Cell. 177:541. PubMed Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed Tang Q, et al. 2021. Immunity. 54:1961. PubMed Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed Otxoa–de–Amezaga A, et al. 2019. Stroke. 50:1548. PubMed Youshani AS, et al. 2019. J Neuroinflammation. 16:25. PubMed Soberanes S et al. 2018. Cell metabolism. 29(2):335-347 . PubMed Nalbandian A, et al. 2017. Inflammation. 40:21:00. PubMed Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Molgora M, et al. 2020. Cell. 182:886. PubMed Walsh CM, et al. 2019. Elife. 8:e48448. PubMed Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed Freed-Pastor WA, et al. 2021. Cancer Cell. 39:1342. PubMed E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed Smith R, et al. 2016. J Leukoc Biol. 100:371-80. PubMed Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed Celorrio M, et al. 2022. Acta Neuropathol Commun. 10:10. PubMed Flak MB, et al. 2020. J Clin Invest. 130:359. PubMed Chen D, et al. 2021. JCI Insight. 6:. PubMed Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed Fearon AE, et al. 2021. iScience. 24:103143. PubMed Matei DE, et al. 2021. Med (N Y). 2:864. PubMed |
|---|
| RRID | AB_10640452 (BioLegend Cat. No. 127621) AB_10643269 (BioLegend Cat. No. 127622) |
|---|
| Structure | A 21-35 kD GPI-anchorded membrane protein |
|---|
| Distribution | Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C. |
|---|
| Cell Type | Granulocytes, Macrophages, Monocytes |
|---|
| Biology Area | Immunology, Innate Immunity |
|---|
| Antigen References | Fleming TJ, et al. 1993. J. Immunol. 151:2399. |
|---|
| Gene ID | 546644 |
|---|
| UniProt | View information about Ly-6G on UniProt.org |
|---|
| Clone | 1A8 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Lymphocyte antigen 6 complex, locus G |
|---|
| Isotype | Rat IgG2a, κ |
|---|
